Case number 2018-1453
UCB, Inc. v. Watson Laboratories Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 31, 2019 | 11 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [624768] [18-1397, 18-1453] [JAB] [Entered: 07/31/2019 10:22 AM] (1) |
| Jun 24, 2019 | 9 | OPINION filed for the court by Taranto, Circuit Judge; Schall, Circuit Judge and Chen, Circuit Judge. Precedential Opinion. [616260] [18-1397, 18-1453] [JAB] [Entered: 06/24/2019 09:46 AM] (34) |
| Jun 24, 2019 | 10 | JUDGMENT filed. AFFIRMED. Terminated on the merits after oral argument. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [616261] [18-1397, 18-1453] [JAB] [Entered: 06/24/2019 09:47 AM] (2) |
| Oct 3, 2018 | 8 | **TEXT ONLY** ORDER denying as moot motion to withdraw attorney [7] filed by Cross-Appellants UCB, Inc., LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH and UCB Manufacturing Ireland Limited. Motion is not required in cross-appeal. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [554458] [SJ] [Entered: 10/03/2018 11:07 AM] (0) |
| Sep 28, 2018 | 7 | MOTION of Cross-Appellants LTS Lohmann Therapie-Systeme AG, UCB Manufacturing Ireland Limited, UCB Pharma GmbH and UCB, Inc. to withdraw counsel Eleanor G. Tennyson [Consent: unopposed]. Service: 09/28/2018 by email. [553442] [18-1453] [Eleanor Tennyson] [Entered: 09/28/2018 06:35 PM] (7) |
| Feb 2, 2018 | 3 | Entry of appearance for Jack B. Blumenfeld as of counsel for Cross-Appellants LTS Lohmann Therapie-Systeme AG, UCB Manufacturing Ireland Limited, UCB Pharma GmbH and UCB, Inc.. Service: 02/02/2018 by email. [494891] [Jack Blumenfeld] [Entered: 02/02/2018 03:28 PM] (2) |
| Feb 2, 2018 | 4 | Entry of appearance for Maryellen Noreika as of counsel for Cross-Appellants LTS Lohmann Therapie-Systeme AG, UCB Manufacturing Ireland Limited, UCB Pharma GmbH and UCB, Inc.. Service: 02/02/2018 by email. [494895] [Jack Blumenfeld] [Entered: 02/02/2018 03:30 PM] (2) |
| Feb 2, 2018 | 5 | Entry of appearance for Derek J. Fahnestock as of counsel for Cross-Appellants LTS Lohmann Therapie-Systeme AG, UCB Manufacturing Ireland Limited, UCB Pharma GmbH and UCB, Inc.. Service: 02/02/2018 by email. [494897] [Jack Blumenfeld] [Entered: 02/02/2018 03:31 PM] (2) |
| Feb 2, 2018 | 6 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [5], attorney entry of appearance Docket No. [4], attorney entry of appearance Docket No. [3], ERROR: documents were submitted in a cross-appeal. CORRECTION: all filings should only be made in lead appeal 18-1397. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [494920] [SJ] [Entered: 02/02/2018 03:51 PM] (0) |
| Jan 23, 2018 | 1 | Appeal docketed. Received: 01/19/2018. [491694]. [SJ] [Entered: 01/23/2018 08:47 AM] (132) |
| Jan 23, 2018 | 2 | Note to file: The following cases are associated:18-1397 (lead) with 18-1453 (cross-appeal). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [491695] [18-1397, 18-1453] [SJ] [Entered: 01/23/2018 08:50 AM] (0) |
